ebselen has been researched along with 2-(4-chlorophenyl)-1,2-benzothiazol-3-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garneau-Tsodikova, S; Green, KD; Ngo, HX; Shrestha, SK | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
2 other study(ies) available for ebselen and 2-(4-chlorophenyl)-1,2-benzothiazol-3-one
| Article | Year |
|---|---|
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Azoles; Dose-Response Relationship, Drug; Isoindoles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship | 2016 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |